Page last updated: 2024-08-21

dronabinol and Drug Refractory Epilepsy

dronabinol has been researched along with Drug Refractory Epilepsy in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Chapman, KE; Galinkin, J; Helmkamp, LJ; Jost, K; Knupp, KG; Rice, JD; Sempio, C1
Cock, H; Cross, JH1
Chang-Douglass, S; Mulvihill, C; Pilling, S1
Cáceres Guido, P; Caraballo, RH; Cruz, CV; García Bournissen, F; Pérez Montilla, CA; Reyes Valenzuela, G; Schaiquevich, PS1
Bitton, J; Bourgeois-Tardif, S; Champagne, PO; Diaz, PL; Hebert, FO; Lewis, E; Major, P; Nowicki, M; Sanon, NT; Sell, E; Weil, AG1
Devinsky, O; Gloss, D; O'Connell, BK1
Goldstein, B; Saneto, R; Sulak, D1

Reviews

2 review(s) available for dronabinol and Drug Refractory Epilepsy

ArticleYear
A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?
    Neuropharmacology, 2020, 06-15, Volume: 170

    Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Culture; Dronabinol; Drug Resistant Epilepsy; Evidence-Based Medicine; Humans; Lennox Gastaut Syndrome

2020
Cannabinoids in treatment-resistant epilepsy: A review.
    Epilepsy & behavior : E&B, 2017, Volume: 70, Issue:Pt B

    Topics: Adult; Anticonvulsants; Cannabidiol; Cannabinoids; Child; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Young Adult

2017

Other Studies

5 other study(ies) available for dronabinol and Drug Refractory Epilepsy

ArticleYear
Prospective evaluation of oral cannabis extracts in children with epilepsy.
    Seizure, 2019, Volume: 72

    Topics: Administration, Oral; Adolescent; Anticonvulsants; Cannabidiol; Cannabis; Child; Child, Preschool; Dronabinol; Drug Resistant Epilepsy; Female; Humans; Male; Medical Marijuana; Plant Extracts; Prospective Studies

2019
Cannabis-based medicinal products: summary of NICE guidance.
    BMJ (Clinical research ed.), 2020, Apr-21, Volume: 369

    Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Decision Making, Shared; Dronabinol; Drug and Narcotic Control; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Needs Assessment; Physicians, Primary Care; Practice Guidelines as Topic; Specialization; United Kingdom; Vomiting

2020
An Ultrafast Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for Cannabidiol Monitoring in Pediatric Refractory Epilepsy.
    Therapeutic drug monitoring, 2021, 10-01, Volume: 43, Issue:5

    Topics: Cannabidiol; Child; Chromatography, High Pressure Liquid; Dronabinol; Drug Resistant Epilepsy; Humans; Limit of Detection; Tandem Mass Spectrometry

2021
Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2022, Volume: 49, Issue:4

    Topics: Cannabidiol; Cannabis; Child; Dronabinol; Drug Resistant Epilepsy; Humans; Plant Extracts; Seizures

2022
The current status of artisanal cannabis for the treatment of epilepsy in the United States.
    Epilepsy & behavior : E&B, 2017, Volume: 70, Issue:Pt B

    Topics: Adolescent; California; Cannabinoids; Cannabis; Child; Child, Preschool; Dronabinol; Drug Resistant Epilepsy; Female; Humans; Infant; Male; Medical Marijuana; Retrospective Studies; Treatment Outcome; United States; Washington

2017